JPH0246023B2 - 33 AMINOO2*22JIMECHIRUPUROPANOORUJUDOTAIOYOBISONOSEIZOHO - Google Patents
33 AMINOO2*22JIMECHIRUPUROPANOORUJUDOTAIOYOBISONOSEIZOHOInfo
- Publication number
- JPH0246023B2 JPH0246023B2 JP14449183A JP14449183A JPH0246023B2 JP H0246023 B2 JPH0246023 B2 JP H0246023B2 JP 14449183 A JP14449183 A JP 14449183A JP 14449183 A JP14449183 A JP 14449183A JP H0246023 B2 JPH0246023 B2 JP H0246023B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino
- same
- following formula
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FNVOFDGAASRDQY-UHFFFAOYSA-N 3-amino-2,2-dimethylpropan-1-ol Chemical class NCC(C)(C)CO FNVOFDGAASRDQY-UHFFFAOYSA-N 0.000 claims description 25
- 239000002253 acid Substances 0.000 claims description 25
- -1 amine compound Chemical class 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 12
- JJMOMMLADQPZNY-UHFFFAOYSA-N 3-hydroxy-2,2-dimethylpropanal Chemical compound OCC(C)(C)C=O JJMOMMLADQPZNY-UHFFFAOYSA-N 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 239000000539 dimer Substances 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 claims description 4
- VVMQUGJVFRVQRN-UHFFFAOYSA-N 3-amino-2,2-dimethylpropanal Chemical compound NCC(C)(C)C=O VVMQUGJVFRVQRN-UHFFFAOYSA-N 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 150000003141 primary amines Chemical class 0.000 claims description 3
- 230000002152 alkylating effect Effects 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000006482 condensation reaction Methods 0.000 description 8
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- FJJYHTVHBVXEEQ-UHFFFAOYSA-N 2,2-dimethylpropanal Chemical compound CC(C)(C)C=O FJJYHTVHBVXEEQ-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical class NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 3
- 229940092714 benzenesulfonic acid Drugs 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229910052500 inorganic mineral Chemical class 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 239000011707 mineral Chemical class 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 150000003460 sulfonic acids Chemical class 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- RWNZSAMXORHQST-UHFFFAOYSA-N 3-[benzyl(methyl)amino]-2,2-dimethylpropan-1-ol Chemical compound OCC(C)(C)CN(C)CC1=CC=CC=C1 RWNZSAMXORHQST-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical class CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WXOWRMDTEXXRQY-UHFFFAOYSA-N 1-amino-2,2-dimethylpropan-1-ol Chemical class CC(C)(C)C(N)O WXOWRMDTEXXRQY-UHFFFAOYSA-N 0.000 description 1
- WKHILFGJMAXBNZ-UHFFFAOYSA-N 3-chloro-2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C=O WKHILFGJMAXBNZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000003445 Hantzsch reaction Methods 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000004729 acetoacetic acid derivatives Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- XKORCTIIRYKLLG-ARJAWSKDSA-N methyl (z)-3-aminobut-2-enoate Chemical compound COC(=O)\C=C(\C)N XKORCTIIRYKLLG-ARJAWSKDSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- OOFMUZPRQRQMQF-UHFFFAOYSA-N n-chloro-n-methyl-1-phenylmethanamine Chemical compound CN(Cl)CC1=CC=CC=C1 OOFMUZPRQRQMQF-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は3―アミノ―2,2―ジメチルプロパ
ノール誘導体及びその製造法に関する。更に詳し
くは、3―(N―アルキル―N―アラルキル)ア
ミノ―2,2―ジメチルプロパノールおよびその
アセト酢酸エステル誘導体およびその製造方法に
関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a 3-amino-2,2-dimethylpropanol derivative and a method for producing the same. More specifically, the present invention relates to 3-(N-alkyl-N-aralkyl)amino-2,2-dimethylpropanol, its acetoacetate derivatives, and methods for producing the same.
本発明で提供される3―アミノ―2,2―ジメ
チルプロパノール誘導体はそれ自体で生理活性を
有し、医薬品として利用し得るばかりでなく医薬
品の中間体としても有用な化合物である。 The 3-amino-2,2-dimethylpropanol derivative provided by the present invention has physiological activity in itself and is a compound that can be used not only as a pharmaceutical but also as an intermediate for pharmaceuticals.
(従来技術)
3―アミノプロパノール類はそれ自体生理活性
を有するばかりでなく、3―アミノプロパノール
等を側鎖基として有する、3―アミノプロパノー
ルを原料として得られる医薬品も種々知られてい
る。(フアルマシアレビユー(No.9)創薬をめざ
す化学P124頁(1982年)日本薬学会)
更に、N,N―ジアルキル―2,2―ジメチル
プロパノール基を生理活性発現性側鎖として有す
る種々のプロトタイプの化合物を修飾した例が知
られている〔M.S.Newmanら,Journal of
Medicinal Chemistry10巻1003頁(1972年)〕。上
述の様に、生理活性発現原子団として3―アミノ
―2,2―ジメチルプロパノール類は薬化学上重
要なものと考えられている。しかしながらその2
位に2ケのメチル基を有し、かつアルキル基とア
ラルキル基で置換されたアミノ基を有する3―
(N―アルキル―N―アラルキルアミノ)―2,
2―ジメチルプロパノール誘導体およびその製造
法は従来文献未知であり知られていない。(Prior Art) 3-Aminopropanols not only have physiological activity in themselves, but also various pharmaceuticals that have 3-aminopropanol or the like as a side chain group and are obtained from 3-aminopropanol as a raw material are also known. (Pharmacia Review (No. 9) Chemistry Aiming for Drug Discovery, p. 124 (1982) Pharmaceutical Society of Japan) In addition, there are various types that have an N,N-dialkyl-2,2-dimethylpropanol group as a physiologically active side chain. Examples of modifications of prototype compounds are known [MS Newman et al., Journal of
Medicinal Chemistry Vol. 10, p. 1003 (1972)]. As mentioned above, 3-amino-2,2-dimethylpropanols are considered to be important in medicinal chemistry as physiologically active atomic groups. However, part 2
3-, which has two methyl groups in the positions and an amino group substituted with an alkyl group and an aralkyl group.
(N-alkyl-N-aralkyl amino)-2,
The 2-dimethylpropanol derivative and its production method are unknown in the literature and unknown.
(発明の目的)
本発明の目的は、従来文献未載の新規なる3―
アミノ―2,2―ジメチルプロパノール誘導体お
よびその製造法を提供することにある。本発明で
提供される3―アミノ―2,2―ジメチルプロパ
ノール類はそれ自体生理活性を有する化合物であ
るばかりでなく、例えば循環器系疾患の治療薬と
して有用な4―フエニル―1,4―ジヒドロピリ
ジン―3,5―ジカルボン酸エステル誘導体の中
間体ともなり得る化合物である。(Object of the invention) The object of the present invention is to create a novel 3-
An object of the present invention is to provide an amino-2,2-dimethylpropanol derivative and a method for producing the same. The 3-amino-2,2-dimethylpropanols provided by the present invention are not only physiologically active compounds themselves, but also 4-phenyl-1,4- which is useful as a therapeutic agent for cardiovascular diseases. It is a compound that can also be an intermediate for dihydropyridine-3,5-dicarboxylic acid ester derivatives.
(発明の構成および効果)
本発明で提供される3―アミノ―2,2―ジメ
チルプロパノール誘導体は下記式〔〕
〔式中、R1はC1〜C4の低級アルキル基、R2は
同一又は異なつて1又は2ケのハロゲン原子,水
酸基,C1〜C4の低級アルキルオキシ基,C1〜C4
の低級ジアルキルアミノ基で置換されているかも
しくは非置換のベンジル基又は同一又は異なつて
1又は2ケのハロゲン原子,水酸基,C1〜C4の
低級アルキルオキシ基,C1〜C4の低級ジアルキ
ルアミノ基で置換されているかもしくは非置換の
フエネチル基,R3は水酸基又はCH3COCH2CO2
―を表わす。〕
で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩である。(Structure and effects of the invention) The 3-amino-2,2-dimethylpropanol derivative provided by the present invention has the following formula [] [In the formula, R 1 is a C 1 to C 4 lower alkyl group, R 2 is the same or different one or two halogen atoms, a hydroxyl group, a C 1 to C 4 lower alkyloxy group, C 1 to C 4
a benzyl group substituted with a lower dialkylamino group or unsubstituted, or the same or different one or two halogen atoms, a hydroxyl group, a C 1 to C 4 lower alkyloxy group, a C 1 to C 4 lower dialkyl Phenethyl group substituted with amino group or unsubstituted, R 3 is hydroxyl group or CH 3 COCH 2 CO 2
- represents. ] A 3-amino-2,2-dimethylpropanol derivative or an acid addition salt thereof.
該3―アミノ―2,2―ジメチルプロパノール
誘導体又はその酸付加塩において、R1は例えば、
メチル,エチル,n―プロピル,iso―プロピル,
n―ブチル等の低級アルキル基を表わし、R2は、
ベンジル基又はフエネチル基であり、ベンジル
基,フエネチル基は、塩素,臭素,沃素,弗素等
のハロゲン原子;水酸基;例えばメトキシ基,エ
トキシ基等のC1〜C4の低級アルキルオキシ基;
例えばジメチルアミノ基等のC1〜C4の低級ジア
ルキルアミノ基の置換基を1ないし2ケ有してい
てもよく、2つの置換基の場合は、同一であつて
も異なつていても良い。本発明の3―アミノ―
2,2―ジメチルプロパノール誘導体はその酸付
加塩であつてもよく、酸付加塩としては3―アミ
ノ―2,2―ジメチルプロパノール誘導体におけ
るアミノ基と、例えば塩酸,硫酸,リン酸等の鉱
酸類;例えばメタンスルホン酸,ベンゼンスルホ
ン酸,p―トルエンスルホン酸等の有機スルホン
酸類;例えば酢酸,フマール酸,マレイン酸,酒
石酸等の一価ないし二価の有機カルボン酸類との
塩が挙げられる。 In the 3-amino-2,2-dimethylpropanol derivative or acid addition salt thereof, R 1 is, for example,
Methyl, ethyl, n-propyl, iso-propyl,
Represents a lower alkyl group such as n-butyl, and R 2 is
A benzyl group or a phenethyl group; a benzyl group or a phenethyl group is a halogen atom such as chlorine, bromine, iodine, or fluorine; a hydroxyl group; a C 1 to C 4 lower alkyloxy group such as a methoxy group or an ethoxy group;
For example, it may have one or two substituents of a C 1 to C 4 lower dialkylamino group such as a dimethylamino group, and in the case of two substituents, they may be the same or different. . 3-amino- of the present invention
The 2,2-dimethylpropanol derivative may be an acid addition salt thereof. Examples of the acid addition salt include the amino group in the 3-amino-2,2-dimethylpropanol derivative and mineral acids such as hydrochloric acid, sulfuric acid, and phosphoric acid. Examples include organic sulfonic acids such as methanesulfonic acid, benzenesulfonic acid and p-toluenesulfonic acid; Examples include salts with monovalent or divalent organic carboxylic acids such as acetic acid, fumaric acid, maleic acid and tartaric acid.
本発明で提供される3―アミノ―2,2―ジメ
チルプロパノール誘導体の具体例として以下のよ
うな化合物があげられる。 Specific examples of the 3-amino-2,2-dimethylpropanol derivative provided by the present invention include the following compounds.
3―(N―ベンジル―N―メチルアミノ)―2,
2―ジメチルプロパノール,
3―(N―ベンジル―N―プロピルアミノ)―
2,2―ジメチルプロパノール,
2,2―ジメチル―3―(N―メチル―N―フエ
ネチルアミノ)プロパノール,
2,2―ジメチル―3―(N―イソプロピル―N
―フエネチルアミノ)プロパノール,
2,2―ジメチル―3―(N―4―ニトロベンジ
ル―N―メチルアミノ)プロパノール,
2,2―ジメチル―3―(N―2,4,6―トリ
クロロベンジル―N―エチルアミノ)―プロパノ
ール,
2,2―ジメチル―3―(N―4―メトキシベン
ジル―N―メチルアミノ)プロパノール,
2,2―ジメチル―3―(N―4―ジメチルアミ
ノベンジル―N―メチルアミノ)プロパノール,
2,2―ジメチル―3―(N―4―アセトアミド
フエネチル―N―メチルアミノ)プロパノール,
アセト酢酸=3―(N―ベンジル―N―メチルア
ミノ)―2,2―ジメチルプロピルエステル,
アセト酢酸=3―(N―ベンジル―N―エチルア
ミノ)―2,2―ジメチルプロピルエステル,
アセト酢酸=3―(N―4―フルオロベンジル―
N―メチルアミノ)―2,2―ジメチルプロピル
エステル,
アセト酢酸=3―(N―3,5―ジクロロベンジ
ル―N―イソプロピルアミノ)―2,2―ジメチ
ルプロピルエステル,
アセト酢酸=3―(N―3,5―ジニトロフエネ
チル―N―メチルアミノ)―2,2―ジメチルプ
ロピルエステル,
アセト酢酸=3―(N―4―メトキシカルボニル
ベンジル―N―メチルアミノ)―2,2―ジメチ
ルプロピルエステル。3-(N-benzyl-N-methylamino)-2,
2-dimethylpropanol, 3-(N-benzyl-N-propylamino)-
2,2-dimethylpropanol, 2,2-dimethyl-3-(N-methyl-N-phenethylamino)propanol, 2,2-dimethyl-3-(N-isopropyl-N
-phenethylamino)propanol, 2,2-dimethyl-3-(N-4-nitrobenzyl-N-methylamino)propanol, 2,2-dimethyl-3-(N-2,4,6-trichlorobenzyl-N- ethylamino)-propanol, 2,2-dimethyl-3-(N-4-methoxybenzyl-N-methylamino)propanol, 2,2-dimethyl-3-(N-4-dimethylaminobenzyl-N-methylamino) ) propanol, 2,2-dimethyl-3-(N-4-acetamidophenethyl-N-methylamino)propanol, acetoacetic acid = 3-(N-benzyl-N-methylamino)-2,2-dimethylpropyl Ester, acetoacetic acid = 3-(N-benzyl-N-ethylamino)-2,2-dimethylpropyl ester, acetoacetic acid = 3-(N-4-fluorobenzyl-
N-methylamino)-2,2-dimethylpropyl ester, acetoacetic acid = 3-(N-3,5-dichlorobenzyl-N-isopropylamino)-2,2-dimethylpropyl ester, acetoacetic acid = 3-(N -3,5-dinitrophenethyl-N-methylamino)-2,2-dimethylpropyl ester, acetoacetic acid =3-(N-4-methoxycarbonylbenzyl-N-methylamino)-2,2-dimethylpropyl ester.
本発明の3―アミノ―2,2―ジメチルプロパ
ノール誘導体でR3が水酸基、すなわち下記式
〔―a〕
〔式中、R1,R2は上記定義に同じである。〕
で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩は下記式〔〕
〔式中、R1は低級アルキル基,R2は置換もし
くは非置換のベンジル基又は置換もしくは非置換
のフエネチル基を表わす。〕
で表わされるアミン化合物又はその酸付加塩と下
記式〔〕
で表わされる3―ヒドロキシ―2,2―ジメチル
プロピオンアルデヒドもしくはその二量体とを還
元的に縮合せしめることによつて製造することが
できる。 In the 3-amino-2,2-dimethylpropanol derivative of the present invention, R 3 is a hydroxyl group, that is, the following formula [-a] [In the formula, R 1 and R 2 are the same as defined above. ] The 3-amino-2,2-dimethylpropanol derivative or its acid addition salt represented by the following formula [] [In the formula, R 1 represents a lower alkyl group, and R 2 represents a substituted or unsubstituted benzyl group or a substituted or unsubstituted phenethyl group. ] An amine compound represented by or its acid addition salt and the following formula [] It can be produced by reductive condensation with 3-hydroxy-2,2-dimethylpropionaldehyde represented by or a dimer thereof.
上記式〔〕で表わされるアミン化合物又はそ
の酸付加塩において、R1およびR2の定義、およ
び具体例は上で詳細に述べたものと同一である。 In the amine compound represented by the above formula [] or its acid addition salt, the definitions and specific examples of R 1 and R 2 are the same as those described in detail above.
上記式〔〕で表わされる3―ヒドロキシ―
2,2―ジメチルプロピオンアルデヒドは、単量
体であつても、二量体であつても良い。即ち、3
―ヒドロキシ―2,2―ジメチルプロピオンアル
デヒドは下記反応式で示すとおり、両者の間に平
衡関係があり熱又は酸で処理することにより平衡
式を右又は左側に一方的に移動させることができ
る〔Hans―Jiirgen Arpe:Chemiker Zeitung97
巻 54頁(1973年)〕。 3-hydroxy- represented by the above formula []
2,2-dimethylpropionaldehyde may be a monomer or a dimer. That is, 3
-Hydroxy-2,2-dimethylpropionaldehyde has an equilibrium relationship between the two, as shown in the reaction formula below, and the equilibrium equation can be unilaterally shifted to the right or left by treatment with heat or acid. Hans―Jiirgen Arpe: Chemiker Zeitung97
Volume 54 (1973)].
本発明によれば、3―ヒドロキシ―2,2―ジ
メチルプロピオンアルデヒドは単量体又は二量体
又はそれらの混合物の状態で用いることができ
る。 According to the invention, 3-hydroxy-2,2-dimethylpropionaldehyde can be used in the form of monomers or dimers or mixtures thereof.
上記式〔〕で表わされるアミン化合物と上記
式〔〕で表わされる3―ヒドロキシ―2,2―
ジメチルプロピオンアルデヒドを還元剤の共存下
に還元的に縮合し、上記式〔―a〕で表わされ
る3―アミノ―2,2―ジメチルプロパノール誘
導体を製造することができる。上記式〔〕で表
わされるアミン化合物と、それとほぼ当量の上記
式〔〕の3―ヒドロキシ―2,2―ジメチルプ
ロピオンアルデヒドとを縮合反応に付すことがで
きる。かかる縮合反応は、例えば塩酸,硫酸等の
鉱酸類;又はメタンスルホン酸,ベンゼンスルホ
ン酸,p―トルエンスルホン酸等の有機スルホン
酸類;トリクロル酢酸,トリフルオロ酢酸等の有
機カルボン酸類等の酸の共存下で行うことができ
る。これらの酸の量は触媒量(0.01当量)ないし
大過剰量(10当量)用いることができる。縮合反
応の温度は0〜150゜好ましくは10〜100℃で行う
ことができる。縮合時に共存して用いることので
きる還元剤はNaBH4,NaBH3CN等の金属水素
錯化合物を挙げることができる。還元的に縮合し
て生成した上記式〔―a〕で表わされる3―ア
ミノ―2,2―ジメチルプロパノール誘導体は通
常の繰作すなわち抽出,蒸留,再結晶,クロマト
グラフイー等により容易に精製することができ
る。 Amine compound represented by the above formula [] and 3-hydroxy-2,2- represented by the above formula []
A 3-amino-2,2-dimethylpropanol derivative represented by the above formula [-a] can be produced by reductively condensing dimethylpropionaldehyde in the presence of a reducing agent. The amine compound represented by the above formula [] and a substantially equivalent amount of 3-hydroxy-2,2-dimethylpropionaldehyde of the above formula [] can be subjected to a condensation reaction. Such a condensation reaction is carried out in the presence of acids such as mineral acids such as hydrochloric acid and sulfuric acid; or organic sulfonic acids such as methanesulfonic acid, benzenesulfonic acid and p-toluenesulfonic acid; and organic carboxylic acids such as trichloroacetic acid and trifluoroacetic acid. You can do it below. The amount of these acids can range from a catalytic amount (0.01 equivalent) to a large excess amount (10 equivalent). The condensation reaction can be carried out at a temperature of 0 to 150°C, preferably 10 to 100°C. Examples of reducing agents that can be used together during condensation include metal hydrogen complex compounds such as NaBH 4 and NaBH 3 CN. The 3-amino-2,2-dimethylpropanol derivative represented by the above formula [-a] produced by reductive condensation can be easily purified by conventional procedures such as extraction, distillation, recrystallization, chromatography, etc. be able to.
3―アミノ―2,2―ジメチルプロパノール誘
導体は遊離塩基として通常の操作により精製単離
することもできるし、又は、反応混合物中より酸
付加塩として、あるいは遊離塩基を単離精製後通
常の操作により酸付加塩として得ることもでき
る。 The 3-amino-2,2-dimethylpropanol derivative can be purified and isolated as a free base using conventional procedures, or as an acid addition salt from the reaction mixture, or after isolation and purification of the free base using conventional procedures. It can also be obtained as an acid addition salt.
本発明によれば、上記式〔―a〕の3―アミ
ノ―2,2―ジメチルプロパノール誘導体又はそ
の酸付加塩は下記式〔〕
で表わされる3―ヒドロキシ―2,2―ジメチル
プロピオンアルデヒドもしくはその二量体と下記
式〔〕
H2N−R2 ……〔〕
〔式中、R2は置換もしくは非置換のベンジル
基又は置換もしくは非置換のフエネチル基を表わ
す。〕
で表わされる一級アミン誘導体とを縮合し、次い
で還元し、窒素原子をアルキル化することによつ
ても製造することができる。 According to the present invention, the 3-amino-2,2-dimethylpropanol derivative of the above formula [-a] or its acid addition salt has the following formula [] 3-Hydroxy-2,2-dimethylpropionaldehyde or its dimer represented by the following formula [] H 2 N-R 2 ... [] [In the formula, R 2 is a substituted or unsubstituted benzyl group or a substituted Or it represents an unsubstituted phenethyl group. ] It can also be produced by condensing with a primary amine derivative represented by the following, followed by reduction, and alkylating the nitrogen atom.
本発明によれば上記式〔〕で表わされる3―
ヒドロキシ―2,2―ジメチルプロピオンアルデ
ヒド(単量体又は二単量体のいずれでもよい)に
上記式〔〕で表わされる一級アミン類(R2は
上記定義と同じ)とを溶媒の存在下又は非存在下
で0゜〜150℃好ましくは室温〜120℃で縮合反応せ
しめることができる。縮合反応は無触媒でも進行
するが、塩酸,硫酸等の鉱酸類;メタンスルホン
酸,ベンゼンスルホン酸,p―トルエンスルホン
酸等の有機スルホン酸類を0.01〜10当量、好まし
くは0.1〜5当量共存させることができるし、苛
性ソーダ,苛性カリウム,炭酸カリウム,炭酸ソ
ーダ等の無機アルカリを0.5〜10当量好ましくは、
0.8〜5当量共存させることもできる。縮合生成
物を還元剤例えばNaBH4,NaBH3CN,
LiBH3CN,LiAlH4等の金属水素錯化合物類;例
えばPd,Pt等の接触還元触媒の存在下で水素ガ
スによる還元;例えば、Zn/CH3CO2H,Li/液
体アンモニア,Na/液体アンモニア等の金属類
で還元することができる。還元剤は例えば
NaBH4,NaBH3CN等の金属水素錯化合物を縮
合反応時に共存せしめて、還元的縮合反応せしめ
ることもできる。還元した化合物と例えばR1−
Cl,R1−Br,R1I等のハロゲン化アルキル類とを
反応せしめて、窒素原子をアルキル化することが
できるし、あるいは還元した化合物とHCHO又
は(HCHO)n,CH3CHO,CH3CH2CHOと
HCO2H,Zn/CH3CO2H,等との還元性物質の
共存下で窒素原子をアルキル化することもでき
る。これらの反応操作,反応条件はいずれも従来
公知の通常の方法より選択することができる。 According to the present invention, 3- expressed by the above formula []
Hydroxy-2,2-dimethylpropionaldehyde (either monomer or dimonomer) is added with a primary amine represented by the above formula [] (R 2 is the same as defined above) in the presence of a solvent or The condensation reaction can be carried out at a temperature of 0° to 150°C, preferably room temperature to 120°C, in the absence of a copolymer. Although the condensation reaction proceeds without a catalyst, mineral acids such as hydrochloric acid and sulfuric acid; and organic sulfonic acids such as methanesulfonic acid, benzenesulfonic acid, and p-toluenesulfonic acid are allowed to coexist in an amount of 0.01 to 10 equivalents, preferably 0.1 to 5 equivalents. Preferably, 0.5 to 10 equivalents of an inorganic alkali such as caustic soda, caustic potassium, potassium carbonate, soda carbonate, etc.
It is also possible to coexist 0.8 to 5 equivalents. The condensation product is treated with a reducing agent such as NaBH 4 , NaBH 3 CN,
Metal hydrogen complex compounds such as LiBH 3 CN, LiAlH 4 ; For example, reduction with hydrogen gas in the presence of a catalytic reduction catalyst such as Pd, Pt; For example, Zn/CH 3 CO 2 H, Li/liquid ammonia, Na/liquid It can be reduced with metals such as ammonia. Reducing agents are e.g.
A reductive condensation reaction can also be carried out by allowing a metal hydrogen complex compound such as NaBH 4 or NaBH 3 CN to coexist during the condensation reaction. The reduced compound and e.g. R 1 −
Nitrogen atoms can be alkylated by reacting with alkyl halides such as Cl, R 1 -Br, R 1 I, or the reduced compound can be reacted with HCHO or (HCHO)n, CH 3 CHO, CH 3 CH 2 CHO and
Nitrogen atoms can also be alkylated in the coexistence of reducing substances such as HCO 2 H, Zn/CH 3 CO 2 H, etc. All of these reaction operations and reaction conditions can be selected from conventionally known methods.
本発明の3―アミノ―2,2―ジメチルプロパ
ノール誘導体でR3がCH3COCH2CO2−,すなわ
ち上記式〔―b〕
〔式中、R1,R2は上記定義に同じである。〕
で表わされる化合物は上記式〔―a〕で表わさ
れる3―アミノ―2,2―ジメチルプロパノール
誘導体又はその酸付加塩に下記式〔〕
で表わされるジケテンを反応せしめることによつ
て製造することができる。 In the 3-amino-2,2-dimethylpropanol derivative of the present invention, R 3 is CH 3 COCH 2 CO 2 -, that is, the above formula [-b] [In the formula, R 1 and R 2 are the same as defined above. ] The compound represented by the following formula [] is added to the 3-amino-2,2-dimethylpropanol derivative represented by the above formula [-a] or its acid addition salt. It can be produced by reacting the diketene represented by
上記式〔―a〕で表わされる3―アミノ―
2,2―ジメチルプロパノール誘導体又はその酸
付加塩とジケテンとを無溶媒又は、ベンゼン,ト
ルエン,ジクロルエタン,四塩化炭素,ジオキサ
ン,THF等の非プロトン性有機溶媒の存在下で
30〜150℃,好ましくは50〜120℃で加熱下反応せ
しめて上記式〔―b〕で表わされるアセト酢酸
のエステル誘導体を製造することができる。本発
明によれば、反応条件は従来公知の文献
〔Organic Synthesis;42巻,28頁;Iwanami et
al:Chem.Pharm.Bull.27巻1426頁(1979年)等〕
の反応条件の範囲内から選択できる。 3-amino- represented by the above formula [-a]
A 2,2-dimethylpropanol derivative or its acid addition salt and diketene are mixed without a solvent or in the presence of an aprotic organic solvent such as benzene, toluene, dichloroethane, carbon tetrachloride, dioxane, THF, etc.
The ester derivative of acetoacetic acid represented by the above formula [-b] can be produced by carrying out the reaction under heating at 30 to 150°C, preferably 50 to 120°C. According to the present invention, the reaction conditions are determined from the conventionally known literature [Organic Synthesis; Vol. 42, p. 28; Iwanami et al.
al: Chem.Pharm.Bull.Volume 27, page 1426 (1979), etc.]
can be selected from within the range of reaction conditions.
本発明により提供されるアセト酢酸の3―アミ
ノ―2,2―ジメチルプロピルエステル〔―
b〕は、Hantzsch反応を用いて、対応する循環
器系疾患治療薬として有用な4―フエニル―1,
4―ジヒドロピリジン―3,5―ジカルボン酸の
3―アミノ―2,2―ジメチルプロピルエステル
誘導体に容易に変換することができる。 3-Amino-2,2-dimethylpropyl ester of acetoacetic acid provided by the present invention [-
b] using the Hantzsch reaction, the corresponding 4-phenyl-1, which is useful as a therapeutic drug for cardiovascular system diseases.
It can be easily converted into a 3-amino-2,2-dimethylpropyl ester derivative of 4-dihydropyridine-3,5-dicarboxylic acid.
本発明によれば上記式〔―a〕の3―アミノ
―2,2―ジメチルプロパノール誘導体は下記式
〔〕
〔式中、R1,R2は上記定義と同じ。〕
で表わされる3―アミノ―2,2―ジメチルプロ
ピオンアルデヒドを還元することによつても製造
することができる。 According to the present invention, the 3-amino-2,2-dimethylpropanol derivative of the above formula [-a] has the following formula [] [In the formula, R 1 and R 2 are the same as defined above. ] It can also be produced by reducing 3-amino-2,2-dimethylpropionaldehyde represented by:
上記式〔〕の3―アミノ―2,2―ジメチル
プロピオンアルデヒドは公知の方法で製造するこ
とができる〔J.A.Faust:Journal of American
Chemical Society81巻2214頁(1959年)〕。本製
造方法に用いることのできる還元剤とは、例え
ば、NaBH4,NaBH3CN,LiAlH4,等の金属水
素錯化合物が好ましく用いられる。反応条件は、
−20゜〜100℃で好ましくは−10゜〜80℃の範囲で、
かつ金属水素錯化合物の反応に用いられる通常の
方法により実施することができる。単離,精製は
通常の方法すなわち抽出法,再結晶法,蒸留法,
クロマトグラフイ法等を用いることができる。 3-Amino-2,2-dimethylpropionaldehyde of the above formula [] can be produced by a known method [JAFaust: Journal of American
Chemical Society Vol. 81, p. 2214 (1959)]. As the reducing agent that can be used in this production method, for example, metal hydrogen complex compounds such as NaBH 4 , NaBH 3 CN, LiAlH 4 , etc. are preferably used. The reaction conditions are
-20° to 100°C, preferably -10° to 80°C,
The reaction can be carried out by a conventional method used for reactions of metal hydrogen complex compounds. Isolation and purification are carried out using conventional methods such as extraction, recrystallization, distillation,
A chromatography method or the like can be used.
以上に詳述した如き製造法によつて製造される
3―アミノ―2,2―ジメチルプロパノール誘導
体は、他の有用な化合物、例えば1,4―ジヒド
ロピリジン―3,5―ジカルボン酸ジエステル誘
導体等に変換し得る化合物であり、またそれ自体
薬理活性を有する化合物としても有用なものであ
る。 The 3-amino-2,2-dimethylpropanol derivative produced by the production method detailed above can be used with other useful compounds, such as 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivatives. It is a compound that can be converted and is also useful as a compound that itself has pharmacological activity.
以下本発明を実施例により更に詳細に説明す
る。 The present invention will be explained in more detail below with reference to Examples.
実施例 1
N―メチルベンジルアミノ塩酸塩(27.2g)を
イソプロパノール(78ml)に加え、次いでイソブ
チルアルデヒド(12.4g)とパラホルムアルデヒ
ド(11.4g)を加えて6時間加熱還流した。反応
混合物より減圧下(20mmHg.約30℃)で溶媒を除
去し、残渣を得た。残渣をCH3OH(200ml)にと
かし、氷冷下撹拌しながら、NaBH4(12g)を少
量ずつ加えた。室温にもどし3時間撹拌した。反
応混合物よりCH3OHを留去し、残渣に20%
NaOH水溶液(40ml)を加えた後、Et2O抽出し、
Et2O層を分取,水洗,乾燥後溶媒を除去した。
得られた残留物を減圧蒸留した。Example 1 N-methylbenzylamino hydrochloride (27.2 g) was added to isopropanol (78 ml), followed by isobutyraldehyde (12.4 g) and paraformaldehyde (11.4 g), and the mixture was heated under reflux for 6 hours. The solvent was removed from the reaction mixture under reduced pressure (20 mmHg, about 30°C) to obtain a residue. The residue was dissolved in CH 3 OH (200 ml), and NaBH 4 (12 g) was added little by little while stirring under ice cooling. The mixture was returned to room temperature and stirred for 3 hours. CH 3 OH was distilled off from the reaction mixture, and 20%
After adding NaOH aqueous solution (40ml), extract with Et2O ,
The Et 2 O layer was separated, washed with water, dried, and the solvent was removed.
The resulting residue was distilled under reduced pressure.
沸点、122―124゜(2mmHg)の留分を集め、3
―(N―ベンジル―N―メチルアミノ)―2,2
―ジメチルプロパノール26.6g(75.6%)を得
た。 Collect the fraction with a boiling point of 122-124° (2 mmHg),
-(N-benzyl-N-methylamino)-2,2
-26.6g (75.6%) of dimethylpropanol was obtained.
物性値は下記のとおり
NMR(CDCl3)δppm:7.2(s,5H),5.65(bs,
1H)3.48(s,2H),3.38(s,2H),2.42
(s,2H),2.18(s,3H),0.93(s,6H),
IR υcm-1 nax(Neat):3400,2980,1450,1360,
1040
MS (m/e):207(M+)
塩酸塩m.p.143―145℃
実施例 2
3―ヒドロキシ―2,2―ジメチルプロピオン
アルデヒド二量体(1.02g)およびN―メチルベ
ンジルアミン1.21gを無水メタノール(20ml)に
加え、氷冷下、p―トルエンスルホン酸(600mg)
を加え、次いでNaBH3CN(950mg)を加えた。
室温にて一夜撹拌した。減圧下に溶媒を留去し残
渣に20%NaOH(5ml)を加え、CH2Cl2抽出し、
CH2Cl2層を分取し、水洗,乾燥後,溶媒を除去
し、得られた無色油状物質をシリカゲルクロマト
グラフイーに付し、3―(N―ベンジル―N―メ
チルアミノ)―2,2―ジメチルプロパノール
(930mg,45%)を得た。このものの物性値は実施
例1と同一の物性値を示した。 The physical property values are as follows: NMR (CDCl 3 ) δppm: 7.2 (s, 5H), 5.65 (bs,
1H) 3.48 (s, 2H), 3.38 (s, 2H), 2.42
(s, 2H), 2.18 (s, 3H), 0.93 (s, 6H), IR υcm -1 nax (Neat): 3400, 2980, 1450, 1360,
1040 MS (m/e): 207 (M + ) Hydrochloride mp 143-145℃ Example 2 3-Hydroxy-2,2-dimethylpropionaldehyde dimer (1.02 g) and N-methylbenzylamine 1.21 g were anhydrous. In addition to methanol (20ml), add p-toluenesulfonic acid (600mg) under ice cooling.
was added followed by NaBH 3 CN (950 mg).
Stir overnight at room temperature. The solvent was distilled off under reduced pressure, 20% NaOH (5 ml) was added to the residue, and the mixture was extracted with CH 2 Cl 2 .
After separating the two CH 2 Cl layers, washing with water and drying, the solvent was removed, and the resulting colorless oil was subjected to silica gel chromatography to obtain 3-(N-benzyl-N-methylamino)-2, 2-dimethylpropanol (930 mg, 45%) was obtained. The physical properties of this product were the same as those of Example 1.
実施例 3
3―ヒドロキシ―2,2―ジメチルプロピオン
アルデヒド(単量体)(1.02g)と、ベンジルア
ミン(1.07g)とを無水CH3OH10mlに加えた。
次いで反応液を氷冷しNaBH3CN(471mg)とp
―トルエンスルホン酸(873mg)を加え30分間撹
拌した。室温にもどし12時間撹拌した。溶媒を留
去し、残渣に20%NaOH水溶液5mlを加え、エ
ーテルで抽出し、エーテル層を分取,水洗,乾燥
し溶媒を留去した。残留物〔NMR,δppm
(CDCl3):7.2(S,5H),3.81(S,2H),3.48
(S,2H),2.50(S,2H),1.8(BS,1H),0.99
(S,6H)〕(1.7g)を得た。残留物に30%
HCHO(2ml)とHCO2H(90%)(1.27g)を加
え、2時間加熱還流(浴温120℃)した。減圧下
で低沸点留分を除去し、残渣物を減圧蒸留し、沸
点122―124゜(2mmHg)の留分を集めると3―
(N―ベンジル―N―メチルアミノ)―2,2―
ジメチルプロパノール1.44g(70%)を得た。物
性値は実施例1と同一であつた。Example 3 3-Hydroxy-2,2-dimethylpropionaldehyde (monomer) (1.02 g) and benzylamine (1.07 g) were added to 10 ml of anhydrous CH 3 OH.
Next, the reaction solution was cooled on ice and added with NaBH 3 CN (471 mg).
-Toluenesulfonic acid (873mg) was added and stirred for 30 minutes. The mixture was returned to room temperature and stirred for 12 hours. The solvent was distilled off, 5 ml of 20% NaOH aqueous solution was added to the residue, and extracted with ether. The ether layer was separated, washed with water, dried, and the solvent was distilled off. Residue [NMR, δppm
(CDCl 3 ): 7.2 (S, 5H), 3.81 (S, 2H), 3.48
(S, 2H), 2.50 (S, 2H), 1.8 (BS, 1H), 0.99
(S,6H)] (1.7 g) was obtained. 30% on residue
HCHO (2 ml) and HCO 2 H (90%) (1.27 g) were added, and the mixture was heated under reflux (bath temperature: 120°C) for 2 hours. The low boiling point fraction is removed under reduced pressure, the residue is distilled under reduced pressure, and the fraction with a boiling point of 122-124° (2 mmHg) is collected.
(N-benzyl-N-methylamino)-2,2-
1.44 g (70%) of dimethylpropanol was obtained. The physical properties were the same as in Example 1.
実施例 4
3―ヒドロキシ―2,2―ジメチルプロピオン
アルデヒド(0.51g)を乾燥ベンゼンにとかし、
次いでベンジルアミンを加えた。発熱反応を併つ
て縮合反応した。ベンゼンを常圧で留去し、残留
物に無水CH3OH(5ml)を加え、次いで
NaBH3CN(314mg)と1.8N―HCl/CH3OH3.6ml
加え、室温で48時間撹拌した。溶媒を留去し残留
物に20%NaOH水溶液(5ml)を加え、エーテ
ルで抽出した。エーテル層を分取,水洗,乾燥
し、エーテルを留去し残留物に30%ホルマリン
(1ml)とHCO2H(0.7ml)を加え、浴温120℃で
1.5時間加熱還流した後減圧下で低沸点留分を除
去した。残留物を蒸留し、3―(N―ベンジル―
N―メチルアミノ)―2,2―ジメチルプロパノ
ール0.6gを得た。物性は実施例1と同一であつ
た。Example 4 3-Hydroxy-2,2-dimethylpropionaldehyde (0.51 g) was dissolved in dry benzene,
Benzylamine was then added. The condensation reaction was accompanied by an exothermic reaction. Benzene was distilled off at normal pressure, anhydrous CH 3 OH (5 ml) was added to the residue, and then
NaBH 3 CN (314 mg) and 1.8N-HCl/CH 3 OH 3.6 ml
The mixture was added and stirred at room temperature for 48 hours. The solvent was distilled off, 20% NaOH aqueous solution (5 ml) was added to the residue, and the mixture was extracted with ether. The ether layer was separated, washed with water, dried, the ether was distilled off, 30% formalin (1 ml) and HCO 2 H (0.7 ml) were added to the residue, and the mixture was heated at a bath temperature of 120°C.
After heating under reflux for 1.5 hours, the low boiling point fraction was removed under reduced pressure. The residue was distilled to give 3-(N-benzyl-
0.6 g of N-methylamino)-2,2-dimethylpropanol was obtained. The physical properties were the same as in Example 1.
実施例 5
2,2―ジメチル―3―(N―ベンジル―N―
メチルアミノ)―2,2―ジメチルプロパノール
2.07gをベンゼン1mlに溶解し、70℃に加温し
た。この溶液にジケテン1.0gをゆつくり滴下し
た。1.5時間撹拌後、溶媒を留去し、残渣をシリ
カゲルクロマトグラフイに付し、ヘキサン―酢酸
エチル溶出画分を濃縮し、目的とするアセト酢酸
―〔2,2―ジメチル―3―(N―ベンジル―N
―メチルアミノ)―2,2―ジメチルプロピル〕
エステル〔油状物質)2.8gを得た。Example 5 2,2-dimethyl-3-(N-benzyl-N-
methylamino)-2,2-dimethylpropanol
2.07g was dissolved in 1ml of benzene and heated to 70°C. 1.0 g of diketene was slowly added dropwise to this solution. After stirring for 1.5 hours, the solvent was distilled off, the residue was subjected to silica gel chromatography, and the hexane-ethyl acetate elution fraction was concentrated to obtain the desired acetoacetic acid-[2,2-dimethyl-3-(N-) Benzyl-N
-Methylamino)-2,2-dimethylpropyl]
2.8 g of ester (oil) was obtained.
物性値
NMR(CDCl3)δppm:7.35(s,5H),3.95
(s,2H),3.57(s,2H),3.38(s,2H),
2.28(s,2H),2.18(s,3H),2.15(s,
3H),0.89(s,6H),
IR υcm-1
max(Neat)3000,1720,1640,1450,
1360,1310,1250,1150,1030
MS (m/e):291(M+)
参考例
3―クロル―2―ニトロベンズアルデヒド185
mgと3―アミノクロトン酸メチル118mgと実施例
5で得られたアセト酢酸―〔2,2―ジメチル―
3―(N―ベンジル―N―メチルアミノ)プロピ
ル〕エステル292mgとをイソプロパノール1mlに
溶解し、暗所で12時間加熱還流した。溶媒を留去
し、残渣をシリカゲルクロマトに付し、循環器治
療薬として有用な2,6―ジメチル―4―(3′―
クロル―2′―ニトロフエニル)―1,4―ジヒド
ロピリジン―3,5―ジカルボン酸―3―メチル
エステル―5―〔(2,2―ジメチル―3―(N
―ベンジル―N―メチルアミノ)プロピル〕エス
テルを精取した。Physical properties NMR (CDCl 3 ) δppm: 7.35 (s, 5H), 3.95
(s, 2H), 3.57 (s, 2H), 3.38 (s, 2H),
2.28 (s, 2H), 2.18 (s, 3H), 2.15 (s,
3H), 0.89 (s, 6H), IR υcm -1 max (Neat) 3000, 1720, 1640, 1450,
1360, 1310, 1250, 1150, 1030 MS (m/e): 291 (M + ) Reference example 3-chloro-2-nitrobenzaldehyde 185
mg, 118 mg of methyl 3-aminocrotonate, and acetoacetic acid obtained in Example 5 -[2,2-dimethyl-
292 mg of 3-(N-benzyl-N-methylamino)propyl]ester was dissolved in 1 ml of isopropanol and heated under reflux in the dark for 12 hours. The solvent was distilled off and the residue was subjected to silica gel chromatography to obtain 2,6-dimethyl-4-(3'-
Chlor-2'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methyl ester-5-[(2,2-dimethyl-3-(N
-benzyl-N-methylamino)propyl] ester was collected.
物性値
NMR(CDCl3)δppm:7.4〜7.0(brs,8H),
6.15(brs,1H),5.28(s,1H),3.92(s,
2H),3.60(s,3H),3.41(s,2H),2.21
(s,8H),2.04(s,3H),0.80(s,6H)
塩酸塩IR(KBr)υcm-1
max:3400,1684,1536,
1480
m.p.182―187゜Physical properties NMR (CDCl 3 ) δppm: 7.4 to 7.0 (brs, 8H),
6.15 (brs, 1H), 5.28 (s, 1H), 3.92 (s,
2H), 3.60 (s, 3H), 3.41 (s, 2H), 2.21
(s, 8H), 2.04 (s, 3H), 0.80 (s, 6H) Hydrochloride IR (KBr) υcm -1 max: 3400, 1684, 1536,
1480 mp182―187゜
Claims (1)
同一又は異なつて1又は2ケのハロゲン原子、水
酸基、C1〜C4の低級アルキルオキシ基、C1〜C4
の低級ジアルキルアミノ基で置換されているかも
しくは非置換のベンジル基又は同一又は異なつて
1又は2ケのハロゲン原子、水酸基、C1〜C4の
低級アルキルオキシ基、C1〜C4の低級ジアルキ
ルアミノ基で置換されているかもしくは非置換の
フエネチル基、R3は水酸基又はCH3COCH2CO2
―を表わす。] で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩。 2 下記式[] [式中、R1は、C1〜C4の低級アルキル基、R2
は同一又は異なつて1又は2ケのハロゲン原子、
水酸基、C1〜C4の低級アルキルオキシ基、C1〜
C4の低級ジアルキルアミノ基で置換されている
かもしくは非置換のベンジル基又は同一又は異な
つて1又は2ケのハロゲン原子、水酸基、C1〜
C4の低級アルキルオキシ基、C1〜C4の低級ジア
ルキルアミノ基で置換されているかもしくは非置
換のフエネチル基を表わす。] で表わされるアミン化合物又はその酸付加塩と下
記式[] で表わされる3―ヒドロキシ―2,2―ジメチル
プロピオンアルデヒドもしくはその二量体とを還
元的に縮合せしめることを特徴とする下記式[
―a] [式中、R1,R2は上記定義に同じである。] で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩の製造法。 3 下記式[] で表わされる3―ヒドロキシ―2,2―ジメチル
プロピオンアルデヒドと下記式[] H2N−R2 …[] [式中、R2は同一又は異なつて1又は2ケの
ハロゲン原子、水酸基、C1〜C4の低級アルキル
オキシ基、C1〜C4の低級ジアルキルアミノ基で
置換されているかもしくは非置換のベンジル基又
は同一又は異なつて1又は2ケのハロゲン原子、
水酸基、C1〜C4の低級アルキルオキシ基、C1〜
C4の低級ジアルキルアミノ基で置換されている
かもしくは非置換のフエネチル基を表わす。] で表わされる一級アミン誘導体とを縮合し次いで
還元し、窒素原子をアルキル化することを特徴と
する下記式[―a] [式中、R1,R2は上記定義に同じである。] で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩の製造法。 4 下記式[―a] [式中、R1,R2は上記定義に同じである。] で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩に下記式[] で表わされるジケテンを反応せしめることを特徴
とする下記式[―b] [式中、R1,R2は上記定義に同じである。] で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩の製造法。 5 下記式[] [式中、R1,R2は上記定義に同じである。] で表わされる3―アミノ―2,2―ジメチルプロ
ピオンアルデヒドを還元することを特徴とする下
記式[―a] [式中、R1,R2は上記定義に同じ。] で表わされる3―アミノ―2,2―ジメチルプロ
パノール誘導体又はその酸付加塩の製造法。[Claims] 1. The following formula [] [In the formula, R 1 is a C 1 to C 4 lower alkyl group, R 2 is the same or different one or two halogen atoms, a hydroxyl group, a C 1 to C 4 lower alkyloxy group, C 1 to C 4
a benzyl group substituted with a lower dialkylamino group or unsubstituted, or the same or different one or two halogen atoms, a hydroxyl group, a C 1 to C 4 lower alkyloxy group, a C 1 to C 4 lower dialkyl Phenethyl group substituted with amino group or unsubstituted, R 3 is hydroxyl group or CH 3 COCH 2 CO 2
- represents. ] A 3-amino-2,2-dimethylpropanol derivative or an acid addition salt thereof. 2 The following formula [] [In the formula, R 1 is a C 1 to C 4 lower alkyl group, R 2
are the same or different and are one or two halogen atoms,
Hydroxyl group, C1 - C4 lower alkyloxy group, C1 - C4
C 4 lower dialkylamino group substituted or unsubstituted benzyl group or the same or different 1 or 2 halogen atoms, hydroxyl group, C 1 -
It represents a phenethyl group substituted with a C 4 lower alkyloxy group or a C 1 to C 4 lower dialkylamino group or unsubstituted. ] An amine compound or its acid addition salt represented by the following formula [] 3-hydroxy-2,2-dimethylpropionaldehyde or its dimer represented by the following formula [
-a] [In the formula, R 1 and R 2 are the same as defined above. ] A method for producing a 3-amino-2,2-dimethylpropanol derivative or an acid addition salt thereof. 3 The following formula [] 3-Hydroxy-2,2-dimethylpropionaldehyde represented by the following formula [] H 2 N-R 2 ... [] [wherein R 2 is the same or different and represents one or two halogen atoms, a hydroxyl group, C 1 to C4 lower alkyloxy group, C1 to C4 lower dialkylamino group substituted or unsubstituted benzyl group, or the same or different 1 or 2 halogen atoms,
Hydroxyl group, C1 - C4 lower alkyloxy group, C1 - C4
Represents a phenethyl group substituted with a C 4 lower dialkylamino group or unsubstituted. ] The following formula [-a], which is characterized by condensing with a primary amine derivative represented by and then reducing, and alkylating the nitrogen atom [In the formula, R 1 and R 2 are the same as defined above. ] A method for producing a 3-amino-2,2-dimethylpropanol derivative or an acid addition salt thereof. 4 The following formula [-a] [In the formula, R 1 and R 2 are the same as defined above. ] The 3-amino-2,2-dimethylpropanol derivative or its acid addition salt represented by the following formula [] The following formula [-b] characterized by reacting diketene represented by [In the formula, R 1 and R 2 are the same as defined above. ] A method for producing a 3-amino-2,2-dimethylpropanol derivative or an acid addition salt thereof. 5 The following formula [] [In the formula, R 1 and R 2 are the same as defined above. ] The following formula [-a] is characterized by reducing 3-amino-2,2-dimethylpropionaldehyde represented by [In the formula, R 1 and R 2 are the same as defined above. ] A method for producing a 3-amino-2,2-dimethylpropanol derivative or an acid addition salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14449183A JPH0246023B2 (en) | 1983-08-09 | 1983-08-09 | 33 AMINOO2*22JIMECHIRUPUROPANOORUJUDOTAIOYOBISONOSEIZOHO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14449183A JPH0246023B2 (en) | 1983-08-09 | 1983-08-09 | 33 AMINOO2*22JIMECHIRUPUROPANOORUJUDOTAIOYOBISONOSEIZOHO |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6036444A JPS6036444A (en) | 1985-02-25 |
| JPH0246023B2 true JPH0246023B2 (en) | 1990-10-12 |
Family
ID=15363565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14449183A Expired - Lifetime JPH0246023B2 (en) | 1983-08-09 | 1983-08-09 | 33 AMINOO2*22JIMECHIRUPUROPANOORUJUDOTAIOYOBISONOSEIZOHO |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0246023B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5791628B2 (en) * | 2009-12-17 | 2015-10-07 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Method for producing higher ethanolamine |
| US20220251279A1 (en) * | 2019-07-05 | 2022-08-11 | Arxada Ag | Method for Preparation of Acetoacetate Ester Compounds |
-
1983
- 1983-08-09 JP JP14449183A patent/JPH0246023B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6036444A (en) | 1985-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4080449A (en) | 1,2,4,5-Tetrahydro-3H-2-benzazepin-3-ones | |
| US5225585A (en) | Production of fluoxetine and new intermediates | |
| JPS63139182A (en) | Production of thiazolidinedione derivative | |
| JPH07316113A (en) | New arylalkyl(thio)amide compound | |
| EP0239461A1 (en) | N-¬¬(hydroxy-2-phenyl)(phenyl)methylene amino-2 ethyl acetamide derivatives, process for their preparation and their therapeutical use | |
| EP0511031B1 (en) | 3-Aryl-oxazolidinon derivatives, process for their preparation and their use in therapeutics | |
| US5089654A (en) | Chalcone derivatives | |
| FR2600647A1 (en) | GLYCINE DERIVATIVES | |
| EP0005091B1 (en) | Monosubstituted piperazines, processes for their preparation and pharmaceutical compositions containing them | |
| PL113012B1 (en) | Method of manufacture of 2/4-substituted piperazinyl-1/-4-aminoquinazolines | |
| FR2581646A1 (en) | Imidazopyridine derivatives, their preparation and their application in therapeutics | |
| JPH03118364A (en) | Preparation of derivative of pyridine carboxylic acid | |
| JPS6252740B2 (en) | ||
| JP3838682B2 (en) | Process for producing 2-methyl-4-oxo-2-cyclohexenecarboxylic acid ester and novel intermediate thereof | |
| JPS62126160A (en) | Novel phenylbutylaldehyde derivative and production thereof | |
| FR2792635A1 (en) | 2-Amino-cyclobutene-3,4-dione cyclohexane carboxamide derivatives are phosphodiesterase inhibitors useful for treating e.g. incontinence, dysmenorrhea, premature labor, sexual dysfunction, angina and asthma | |
| EP0663394B1 (en) | Process for preparing 5-aminodihydropyrrole, intermediate thereof and process for preparing said intermediate | |
| JP3918468B2 (en) | 3,3-bis (alkoxycarbonyl-methylthio) propionitrile and process for producing the same | |
| FR2792634A1 (en) | New 2-alkoxy cyclobutene-3,4-dione derivatives are phosphodiesterase-5 inhibitors, useful for treating e.g. incontinence, dysmenorrhea, premature labor, sexual dysfunction, angina and asthma | |
| JPS61118348A (en) | Manufacture of hydroxymethylenealkoxyacetic acid ester | |
| KR100194062B1 (en) | Method for preparing 2-cyclohexenone having various substituents | |
| JP4032593B2 (en) | Method for producing 4-aminotetrahydropyran derivative | |
| JPS6036444A (en) | 3-amino-2,2-dimethylpropanol derivative and its preparation | |
| KR100365526B1 (en) | Synthesis of the bicyclo[3.3.1]nonane structure | |
| JPS649987B2 (en) |